All Stories

  1. Recent Advances in Treatment of Childhood Obesity
  2. Gender Dysphoria, Eating Disorders and Body Image: An Overview
  3. Obesity: the New Global Epidemic. Pharmacological Treatment, Opportunities and Limits for Personalized Therapy.
  4. Eating Disorders in Athletes: From Risk Management to Therapy
  5. Antimicrobial Activity, Antioxidant Properties and Phytochemical Screening of Aesculus hippocastanum Mother Tincture against Food-borne Bacteria
  6. Psychopharmacological Options in the Multidisciplinary and Multidimensional Treatment of Eating Disorders
  7. Medical Complications in Anorexia and Bulimia Nervosa
  8. Neuroendocrine and Metabolic Disorders in Bulimia Nervosa
  9. Changes in the Peripheral Endocannabinoid System as a Risk Factor for the Development of Eating Disorders
  10. Protective and Restorative Effects of Nutrients and Phytochemicals
  11. Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview
  12. Involvement of nutrients and nutritional mediators in mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene expression
  13. Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment Approach
  14. Cannabinoids for the Treatment of Schizophrenia: An Overview
  15. Effect of Docosahexaenoic Acid on Cell Cycle Pathways in Breast Cell Lines With Different Transformation Degree
  16. (6-Bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (Carbhydraz) Acts as a GPER Agonist in Breast Cancer Cells
  17. Crystallographic Study and Biological Evaluation of 1,4-dimethyl-N-alkylcarbazoles†
  18. Cycloartane glycosides from Astragalus plumosus var. krugianus and evaluation of their antioxidant potential
  19. Agomelatine in NES
  20. Steroidal Glycosides with Antiproliferative Activities from Digitalis trojana
  21. The Involvement of Xanthohumol in the Expression of Annexin in Human Malignant Glioblastoma Cells
  22. Antioxidant Action and Therapeutic Efficacy of Allium sativum L.
  23. Agomelatine Efficacy in the Night Eating Syndrome
  24. Cyclohexa-2,5-diene-1,4-dione-based antiproliferative agents: design, synthesis, and cytotoxic evaluation
  25. Role of Lipid Rafts/Caveolae in the Anticancer Effect of Endocannabinoids
  26. Migraine and Genetic Polymorphisms: An Overview
  27. Vinorelbine in Cancer Therapy
  28. Antiproliferative steroidal glycosides from Digitalis ciliata
  29. Cycloartane glycosides from Astragalus stereocalyx Bornm.
  30. Potentially toxic elements, pollution and hair
  31. Iridoid, phenylethanoid and flavonoid glycosides from Sideritis trojana
  32. Xanthohumol Induces Apoptosis in Human Malignant Glioblastoma Cells by Increasing Reactive Oxygen Species and Activating MAPK Pathways
  33. Interconverting flavanone glucosides and other phenolic compounds in Lippia salviaefolia Cham. ethanol extracts
  34. Triterpenoid Constituents from the Roots of Paeonia rockii ssp. rockii
  35. Night eating syndrome: an overview
  36. Duloxetine in the Treatment of Depression: An Overview
  37. Neuroinflammation and Ageing: Current Theories and an Overview of the Data
  38. Neuroinflamm-Aging and Neurodegenerative Diseases: An Overview
  39. Efficacy and Tolerability of Vinorelbine in the Cancer Therapy
  40. Xolair in Asthma Therapy: An Overview
  41. Recent Clinical Aspects of Hyperprolactinemia Induced by Antipsychotics
  42. Sesquiterpene Coumarins from Ferula gumosa
  43. Post-natal stress-induced endocrine and metabolic alterations in mice at adulthood involve different pro-opiomelanocortin-derived peptides
  44. Functional Interference of Dexamethasone on Some Morphine Effects: Hypothesis for the Steroid-Opioid Interaction: An Updated
  45. Sexual dimorphic evolution of metabolic programming in non-genetic non-alimentary mild metabolic syndrome model in mice depends on feed-back mechanisms integrity for pro-opiomelanocortin-derived endogenous substances
  46. Potential Therapeutic Effects of Vitamin E and C on Placental Oxidative Stress Induced by Nicotine: An In Vitro Evidence
  47. Saponins and Polyphenols from Fadogia ancylantha (Makoni Tea)
  48. Circadian and ultradian rhythms in locomotory activity of inbred strains of mice
  49. Molecules Acting on CB1 Receptor and their Effects on Morphine Withdrawal In Vitro
  50. A Multicentre Database for Normative Brainstem Auditory Evoked Potentials (BAEPs) in Children: Methodology for Data Collection and Evaluation
  51. Migraine: An Overview
  52. Functional Interaction Between Purinergic System and Opioid Withdrawal: In Vitro Evidence
  53. β-Endorphin Fragments DTγE and DEγE Reduced Morphine Inhibition of Electrically-Induced Contractions and Opiate Withdrawal
  54. α 2-Adrenoceptor Antagonist SL84.0418 Involvement in the Development of Opioid Withdrawal
  55. Neurobiology of Pain in Children: An Overview
  56. Pharmacological Profile of SSRIs and SNRIs in the Treatment of Eating Disorders
  57. Involvement of Serotonin in the Acute Dependence Produced by μ, and K Opioid Agonists
  58. Recent Clinical Aspects of Eating Disorders
  59. Effects of Vitamin E and C on Placental Oxidative Stress: An In Vitro Evidence for the Potential Therapeutic or Prophylactic Treatment of Preeclampsia
  60. The Involvement of Prostaglandins and Nitric Oxide in the Development of Brain Excitability: A Relationship Study
  61. Methisergide Selective Inhibition of Opioid Acute Physical Dependence in Isolated Tissues
  62. Functional Interference of Dexamethasone on Some Morphine Effects:Hypothesis for the Steroid-Opioid Interaction
  63. The Effects of the 3,4-Methylenedioxymethamphetamine (Ecstasy) in Some Cerebral Areas: Role of the Oxidative Stress
  64. The β-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians
  65. The Effect of Morphine on the Expression of COX-2 and iNOS Enzymes
  66. Dopamine Receptors are Involved in the Control of Opioid Antinociception in Mice
  67. Selective Inhibition of Neuronal Nitric Oxide Synthase by L-Arginine Derivatives
  68. In Vitro Binding Receptors Study by Valeriana adscendens, Iresine herbstii and Brugmansia arborea Extracts
  69. Synthesis and Biological Activity of a New Class of Azetidinones Compounds as Potential HLE Inhibitors
  70. Bioactivity of New μ and δ Opioid Peptides
  71. The Effect of Flavonol Glycosides on Opiate Withdrawal
  72. Design of Molecules Acting on the Serotonin Receptors
  73. Glucocorticoids Involvement in the Control of CNS Excitability
  74. Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists
  75. The Role of Muscarinic Receptors in the Control of Acute Opioid Withdrawal
  76. Evaluation of antioxidative properties ofAllium species growing wild in Italy
  77. Differential effects of three species ofHypericum in an open field test
  78. Binding studies for serotoninergic, dopaminergic and noradrenergic receptors of Valeriana adscendens Trel. extracts
  79. Administration of antisense oligonucleotide against pro-opiomelanocortin prevents enduring hormonal alterations induced by neonatal handling in male mice
  80. Affinity of Iresine herbstii and Brugmansia arborea extracts on different cerebral receptors
  81. In vitro antiproliferative effect of sixSalvia species on human tumor cell lines
  82. Erratum to “Neurophysiological studies of Heteropteris glabra Hok. & Arn. (Malpighiaceae) in DBA/2J mice” [Journal of Ethnopharmacology 97 (2005) 415–419]
  83. Neurophysiological studies of Heteropteris glabra Hok. & Arn. (Malpighiaceae) in DBA/2J mice
  84. Pharmacological activity of new μ, δ, κ receptor agonists and antagonists
  85. Petrosaspongiolide M reduces morphine withdrawal in vitro
  86. Pharmacological Studies and Synthesis of Morpholino Alkyl Derivatives.
  87. α2-Adrenoceptor antagonist SL 84.0418 reduces the expression of neocortical spike-and-wave spindling episodes in DBA/2J mice
  88. The effect of papaverine on acute opiate withdrawal in guinea pig ileum
  89. Alkaloids fromBrugmansia arborea (L.) Lagerhein reduce morphine withdrawalin vitro
  90. Vas deferens response to selective opioid receptor agonists in adult mice is impaired following postnatal repeated mild stress
  91. Dexamethasone reduces morphine-induced straub reaction in mice
  92. Central Nervous System Pharmacological Effects of Plants from Northern Peruvian Andes: Valeriana adscendens, Iresine herbstii and Brugmansia arborea
  93. β-Endorphin fragments (DTγE and DEγE) reduce opiate withdrawal in guinea pig ileum
  94. Pharmacological Studies and Synthesis of Morpholino Alkyl Derivatives
  95. Dexamethasone modulates hypotension induced by opioids in anaesthetised rats
  96. Purinoreceptors are involved in the control of acute morphine withdrawal
  97. Involvement of nuclear factor-kB in the expression of opiate withdrawal
  98. Clonidine-induced antinociception and locomotor hypoactivity are reduced by dexamethasone in mice
  99. Saponins from the roots of Zygophyllum gaetulum and their effects on electrically-stimulated guinea-pig ileum
  100. Flavonol glycosides from Aristeguietia discolor reduce morphine withdrawal in vitro
  101. Constituents ofCroton menthodorus and their effects on electrically induced contractions of the guinea-pig isolated ileum
  102. Adenosine receptors are involved in the control of acute naloxone-precipitated withdrawal: In vitro evidence
  103. Flavonol glycosides from Aristeguietia discolor reduce morphine withdrawal in vitro
  104. New protopine alkaloids fromAristolochia constricta reduce morphine withdrawalin vitro
  105. Guinea-pigs treated with β-endorphin fragments DTγE and DEγE exhibit reduced morphine inhibition of electrically-induced contractions
  106. Further studies on the involvement of the arachidonic acid cascade in the acute dependence produced by μ, κ and δ opioid agonists in isolated tissues
  107. GABAB receptors are involved in the control of acute opiate withdrawal in isolated tissue
  108. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with μ- and k-opioid receptor agonists
  109. Phytochemical and Pharmacological Studies of Guettarda acreana
  110. Properties and Effects on Isolated Guinea-Pig Ileum of Zygophyllum gaetulum Species Endemic in Moroccan Sahara
  111. Flavonol Glycosides from Croton menthodorus Reduce in vitro Morphine Withdrawal
  112. Rational design of dynorphin A analogues with δ-receptor selectivity and antagonism for δ- and κ-receptors
  113. New Protopine and Benzyltetrahydroprotoberberine Alkaloids from Aristolochia constricta and Their Activity on Isolated Guinea-Pig Ileum
  114. Dexamethasone inhibition of acute opioid physical dependence in vitro is reverted by anti-lipocortin-1 and mimicked by anti-type II extracellular PLA2 antibodies
  115. Synthesis and Pharmacological Activity of Deltorphin and Dermorphin-Related Glycopeptides
  116. Arachidonic acid and its metabolites are involved in the expression of morphine dependence in guinea-pig isolated ileum
  117. Different Effects of Some Isoquinoline Alkaloids fromArgemone mexicana on Electrically Induced Contractions of Isolated Guinea-pig Ileum
  118. Different Effects of Some Isoquinoline Alkaloids from Argemone mexicana on Electrically Induced Contractions of Isolated Guinea‐pig Ileum
  119. GABAA receptor antagonists reduce acute opiate withdrawal in isolated tissue
  120. FLAVONOLGLYCOSIDESFROMARISTEGUIETIA DISCOLORAND THEIRINHIBITORYACTIVITYON ELECTRICALLY-STIMULATEDGUINEAPIGILEUM
  121. Pharmacokinetic and pharmacodynamic profile of triethylene glycol indomethacin ester as a new oral prodrug
  122. Analgesic Effects Induced by Hypoxoside, a Norlignan Glucoside fromHypoxis spp.
  123. Dmt-Tic-OH, a highly selective and potent δ-opioid dipeptide receptor antagonist after systemic administration in the mouse
  124. Opioid receptor selectivity alteration by single residue replacement: synthesis and activity profile of [Dmt1]deltorphin B
  125. Dexamethasone pretreatment reduces the psychomotor stimulant effects induced by cocaine and amphetamine in mice
  126. Opioids regulation on neocortical spindling episodes of DBA/2J mice
  127. Dexamethasone reduced clonidi-induced antinociception in mice
  128. Effect of des-tyrosine-γ-endorphin on neocortical spike-and-wave spindling in DBA/2J mice
  129. Dexamethasone influence on morphine-induced analgesia in outbred Swiss and Inbred DBA/2J and C57BL/6 mice
  130. Dexamethasone and Hormones Related to the Hypothalamic-Pituitary-Adrenal Axis Modulate Inherited Neocortical Spindling in DBA/2J Mice
  131. Effects induced by cysteamine on chemically-induced nociception in mice
  132. Phencyclidine reduces inherited neocortical spindling in DBA/2J mice
  133. Differential sensitivity to dexamethasone influence on morphine antinociception in two different strains of mice: DBA/2J and C57BL/6
  134. Central interaction of dexamethasone and RU-38486 on morphine antinociception in mice
  135. Dexamethasone induces biphasic effect on morphine hypermotility in mice: A dose-related phenomenon
  136. Effect of RU-38486 on dexamethasone reversal of morphine-induced constipation in mice